Neuroscience News and Research

RSS

Researchers produce high-resolution crystal structure of enzyme critical to SARS-CoV-2 survival

A team of Mount Sinai researchers has produced a high-resolution crystal structure of an enzyme essential to the survival of SARS-CoV-2, the virus that causes COVID-19.

9 Sep 2022

Study helps understand how dietary therapies work for epilepsy

Calorie restriction has long been associated with reduced seizures in epilepsy. New research from Boston Children's Hospital helps explain how fasting affects neurons in the brain and could lead the way to new approaches that would avoid the need for fasting or restrictive diets. The findings were published August 30 in the journal Cell Reports.

9 Sep 2022

Infections during pregnancy may not pose great risk to the baby's brain, study shows

Infections in pregnant women have been linked to an increased risk of neurodevelopmental conditions, such as autism, in the child later in life. But it does not seem to be the infections themselves that cause autism, researchers from Karolinska Institutet in Sweden show in a study published in The Lancet Psychiatry.

8 Sep 2022

Annual flu shot may be linked with lower risk of stroke

Getting an annual flu shot may be associated with a lower risk of stroke, according to a study published in the September 7, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

8 Sep 2022

AbbVie to present data from its robust migraine portfolio at the Migraine Trust International Symposium 2022

AbbVie today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium (MTIS) 2022, taking place in London from September 8-11.

From AbbVie 8 Sep 2022

Study helps reveal the molecular secrets of macular degeneration

Research led by Sanford Burnham Prebys professor Francesca Marassi, Ph.D., is helping to reveal the molecular secrets of macular degeneration, which causes almost 90% of all age-related vision loss.

7 Sep 2022

Older people with insomnia more likely to develop memory decline, finds study

A new Canadian study has found that older people with insomnia are at greater risk of developing memory decline and long-term cognitive impairment such as dementia.

6 Sep 2022

Somatostatin neurons' properties are specialized in different subregions of the cortex, finds study

The brain's cerebral cortex is made up of distinct regions involved in myriad processes, from sensory perception to cognitive functions like memory, attention, and decision-making. University of Pittsburgh neuroscience researchers have found that the properties of one neuron subtype - somatostatin neurons - are specialized in different subregions of the cortex.

6 Sep 2022

Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder

Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S. Food & Drug Administration for the SAINTTM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.

6 Sep 2022

New method can accurately, quickly predict which antigens will lead to strong immune response

A cell's secrets can be divulged by its surface, decorated with tens to hundreds of thousands of molecules that help immune cells determine friend from foe.

5 Sep 2022

Combined stem cell and gene therapy shows promise to treat patients with ALS

Cedars-Sinai investigators have developed an investigational therapy using support cells and a protective protein that can be delivered past the blood-brain barrier.

5 Sep 2022

Study investigates the effect of tRNS in a variety of settings

Though many of us may seek a quiet place in which to study, 'noise' may play a key role in helping some people improve their learning potential.

5 Sep 2022

Bats pose little zoonotic danger to humans, study says

A new Tel Aviv University study rejects assertions, according to which the origin of the COVID-19 outbreak is in bats. According to the study, bats have a highly effective immune system that enables them to deal relatively easily with viruses considered lethal for other mammals.

5 Sep 2022

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Anxiety, autism, schizophrenia and Tourette syndrome each have their own distinguishing characteristics, but one factor bridging these and most other mental disorders is circadian rhythm disruption, according to a team of neuroscience, pharmaceutical sciences and computer science researchers at the University of California, Irvine.

2 Sep 2022

Depletion of reactive astrocytes regresses glioblastoma

A groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cancer. The researchers achieved the outcome using a method they developed based on their discovery of two critical mechanisms in the brain that support tumor growth and survival: one protects cancer cells from the immune system, while the other supplies the energy required for rapid tumor growth. The work found that both mechanisms are controlled by brain cells called astrocytes, and in their absence, the tumor cells die and are eliminated.

2 Sep 2022

Neuroscience News and Research

Researchers produce high-resolution crystal structure of enzyme critical to SARS-CoV-2 survival

Study helps understand how dietary therapies work for epilepsy

Infections during pregnancy may not pose great risk to the baby's brain, study shows

Annual flu shot may be linked with lower risk of stroke

AbbVie to present data from its robust migraine portfolio at the Migraine Trust International Symposium 2022

Study helps reveal the molecular secrets of macular degeneration

Older people with insomnia more likely to develop memory decline, finds study

Somatostatin neurons' properties are specialized in different subregions of the cortex, finds study

Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder

New method can accurately, quickly predict which antigens will lead to strong immune response

Combined stem cell and gene therapy shows promise to treat patients with ALS

Study investigates the effect of tRNS in a variety of settings

Bats pose little zoonotic danger to humans, study says

Circadian rhythm disruption is shared by a broad range of mental illnesses, study finds

Depletion of reactive astrocytes regresses glioblastoma

Gene variants associated with blood type may contribute to risk of early stroke

Early therapeutic interventions may be effective in treating Fragile X Syndrome

Inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth

Simple blood test may identify patients at high risk of neurotoxic complications after CAR-T cell therapy

Food for thought: ventral visual pathway has neural populations that respond very selectively to images of food

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News